PCVX EBITDA Growth
Vaxcyte Inc · EBITDA Growth
PCVX EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-116.15%period ending
PCVX TTM EBITDA YoY % (-79.16% → -116.15%)
Year-over-year change
High-resolution chart · PNG
PCVX ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -116.1527% | |
| -105.1512% | |
| -83.2105% | |
| -5.1853% | |
| 3.7243% | |
| 2.6429% | |
| 7.4022% | |
| -58.1899% | |
| -78.8251% | |
| -87.4883% | |
| -103.9713% | |
| -101.9257% | |
| -106.9482% | |
| -118.3302% | |
| -117.5469% | |
| -81.2205% | |
| -57.3998% | |
| -34.5907% | |
| -12.2214% | |
| -12.1226% | |
| -20.1414% | |
| -34.0973% | |
| -79.1646% |